Judith M. Gottwein

4.4k citations

75 papers · 3.4k indexed · 1 hit paper · h-index 33

Hepatology top 0.2%
- Hepatitis C virus research 54
Epidemiology top 1%
- Hepatitis B Virus Studies 50
- Liver Disease Diagnosis and Treatment 21
Virology top 2%
Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research 12
- SARS-CoV-2 detection and testing 5
- COVID-19 Clinical Research Studies 4
Radiology, Nuclear Medicine and Imaging top 2%
- Monoclonal and Polyclonal Antibodies Research 18
Animal Science and Zoology
- Animal Virus Infections Studies 7

Co-authors: Jens Bukh Troels K. H. Scheel Tanja B. Jensen Santseharay Ramírez Yi‐Ping Li Jannick Prentoe Anne Mette Hoegh Lotte S. Mikkelsen
Cited by: Hepatology Epidemiology Virology
Partner nations: Denmark United States Germany

In The Last Decade

Judith M. Gottwein

73 papers receiving 3.4k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2022 Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system

Peers

Countries citing papers authored by Judith M. Gottwein

Since Specialization

Citations

This map shows the geographic impact of Judith M. Gottwein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith M. Gottwein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith M. Gottwein more than expected).

Fields of papers citing papers by Judith M. Gottwein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith M. Gottwein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith M. Gottwein. The network helps show where Judith M. Gottwein may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Judith M. Gottwein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Judith M. Gottwein Line = papers co-authored together Judith M. Gottwein links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	An inactivated SARS-CoV-2 vaccine based on a Vero cell culture-adapted high-titer virus confers cross-protection in small animals Anna Offersgaard,Carlos R. Duarte Hernandez,Yuyong Zhou,Z. H. Duan,Karen Anbro Gammeltoft,Katrine Top Hartmann,Ulrik Fahnøe,Pavel Marichal‐Gallardo,Garazi Peña Alzua,Alexander P. Underwood,Christina Sølund,Nina Weis,Jesper Bonde,Jan Pravsgaard Christensen,Gabriel Kristian Pedersen,Henrik Elvang Jensen,Kenn Holmbeck,Jens Bukh,Judith M. Gottwein	2024	1
2	Characterization of multi-DAA resistance using a novel hepatitis C virus genotype 3a infectious culture system Carlota Fernandez-Antunez,Kuan Wang,Ulrik Fahnøe,Lotte S. Mikkelsen,Judith M. Gottwein,Jens Bukh,Santseharay Ramírez	2023	4
3	Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture systembreakdown → Yuyong Zhou,Karen Anbro Gammeltoft,Line A. Ryberg,Long V. Pham,Helena D. Tjørnelund,Alekxander Binderup,Carlos Rene Duarte Hernandez,Carlota Fernandez-Antunez,Anna Offersgaard,Ulrik Fahnøe,Günther H. Peters,Santseharay Ramírez,Jens Bukh,Judith M. Gottwein	2022	132
4	Versatile SARS-CoV-2 Reverse-Genetics Systems for the Study of Antiviral Resistance and Replication Ulrik Fahnøe,Long V. Pham,Carlota Fernandez-Antunez,Rui Costa,Lizandro R. Rivera-Rangel,Andrea Galli,Shan Feng,Lotte S. Mikkelsen,Judith M. Gottwein,Troels K. H. Scheel,Santseharay Ramírez,Jens Bukh	2022	24
5	Inactivated whole hepatitis C virus vaccine employing a licensed adjuvant elicits cross-genotype neutralizing antibodies in mice Anne Finne Pihl,Shan Feng,Anna Offersgaard,Garazi Peña Alzua,Elias H. Augestad,Christian K. Mathiesen,Tanja B. Jensen,Henrik Krarup,Mansun Law,Jannick Prentoe,Jan Pravsgaard Christensen,Jens Bukh,Judith M. Gottwein	2022	16
6	Efficacy of Ion-Channel Inhibitors Amantadine, Memantine and Rimantadine for the Treatment of SARS-CoV-2 In Vitro Yuyong Zhou,Karen Anbro Gammeltoft,Andrea Galli,Anna Offersgaard,Ulrik Fahnøe,Santseharay Ramírez,Jens Bukh,Judith M. Gottwein	2021	24
7	Overcoming Culture Restriction for SARS-CoV-2 in Human Cells Facilitates the Screening of Compounds Inhibiting Viral Replication Santseharay Ramírez,Carlota Fernandez-Antunez,Andrea Galli,Alexander P. Underwood,Long V. Pham,Line A. Ryberg,Shan Feng,Martin Schou Pedersen,Lotte S. Mikkelsen,Sandrine Belouzard,Jean Dubuisson,Christina Sølund,Nina Weis,Judith M. Gottwein,Ulrik Fahnøe,Jens Bukh	2021	63
8	Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 In Vitro Karen Anbro Gammeltoft,Yuyong Zhou,Carlos R. Duarte Hernandez,Andrea Galli,Anna Offersgaard,Rui Costa,Long V. Pham,Ulrik Fahnøe,Shan Feng,Troels K. H. Scheel,Santseharay Ramírez,Jens Bukh,Judith M. Gottwein	2021	37
9	Antigenic and immunogenic evaluation of permutations of soluble hepatitis C virus envelope protein E2 and E1 antigens Jannick Prentoe,Christoph M. Janitzek,Rodrigo Velázquez‐Moctezuma,Louise Goksøyr,Rebecca W. Olsen,Margherita Fanalista,Elias H. Augestad,Susan Thrane,Anne Finne Pihl,Judith M. Gottwein,Adam F. Sander,Jens Bukh	2021	2
10	Development of a downstream process for the production of an inactivated whole hepatitis C virus vaccine Keven Lothert,Anna Offersgaard,Anne Finne Pihl,Christian K. Mathiesen,Tanja B. Jensen,Garazi Peña Alzua,Ulrik Fahnøe,Jens Bukh,Judith M. Gottwein,Michael W. Wolff	2020	25
11	HCV genotype 1-6 NS3 residue 80 substitutions impact protease inhibitor activity and promote viral escape Long V. Pham,Sanne B. Jensen,Ulrik Fahnøe,Martin Schou Pedersen,Qi Tang,Lubna Ghanem,Santseharay Ramírez,Daryl Humes,Stéphanie B. N. Serre,Kristian Schønning,Jens Bukh,Judith M. Gottwein	2018	32
12	Recombinant hepatitis C virus genotype 5a infectious cell culture systems expressing minimal JFH1 NS5B sequences permit polymerase inhibitor studies Daryl Humes,Santseharay Ramírez,Tanja B. Jensen,Yi‐Ping Li,Judith M. Gottwein,Jens Bukh	2018	3
13	Robust HCV Genotype 3a Infectious Cell Culture System Permits Identification of Escape Variants With Resistance to Sofosbuvir Santseharay Ramírez,Lotte S. Mikkelsen,Judith M. Gottwein,Jens Bukh	2016	68
14	Cell-culture-derived HCV—a promising vaccine antigen Judith M. Gottwein,Jens Bukh	2013	13
15	Productive Homologous and Non-homologous Recombination of Hepatitis C Virus in Cell Culture Troels K. H. Scheel,Andrea Galli,Yi‐Ping Li,Lotte S. Mikkelsen,Judith M. Gottwein,Jens Bukh	2013	42
16	Non-genotype-specific role of the hepatitis C virus 5′ untranslated region in virus production and in inhibition by interferon Yi‐Ping Li,Santseharay Ramírez,Judith M. Gottwein,Jens Bukh	2011	18
17	Chapter 2 Cutting the Gordian Knot-Development and Biological Relevance of Hepatitis C Virus Cell Culture Systems Judith M. Gottwein,Jens Bukh	2008	83
18	Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: Role of CD81 and scavenger receptor class B type I and effect of antiviral drugs # † Judith M. Gottwein,Troels K. H. Scheel,Tanja B. Jensen,Jacob B. Lademann,Jannick Prentoe,Maria L. Knudsen,Anne Mette Hoegh,Jens Bukh	2008	304
19	Highly Efficient JFH1‐Based Cell‐Culture System for Hepatitis C Virus Genotype 5a: Failure of Homologous Neutralizing‐Antibody Treatment to Control Infection Tanja B. Jensen,Judith M. Gottwein,Troels K. H. Scheel,Anne Mette Hoegh,Jesper Eugen‐Olsen,Jens Bukh	2008	96
20	Prionen als Motor der transmissiblen spongiformen Enzephalopathien Markus Glatzel,Judith M. Gottwein,Adriano Aguzzi	2002	1

About Judith M. Gottwein

Judith M. Gottwein is a scholar working on Hepatology, Epidemiology and Infectious Diseases, having authored 75 papers that have together received 3.4k indexed citations. Recurring topics across this work include Hepatitis C virus research (54 papers), Hepatitis B Virus Studies (50 papers), Liver Disease Diagnosis and Treatment (21 papers), Monoclonal and Polyclonal Antibodies Research (18 papers), SARS-CoV-2 and COVID-19 Research (12 papers), Animal Virus Infections Studies (7 papers), SARS-CoV-2 detection and testing (5 papers) and COVID-19 Clinical Research Studies (4 papers). The work is most often cited by research in Hepatology (2.6k citations), Epidemiology (2.4k citations) and Virology (238 citations). Judith M. Gottwein has collaborated with scholars based in Denmark, United States and Germany. Frequent co-authors include Jens Bukh, Troels K. H. Scheel, Tanja B. Jensen, Santseharay Ramírez, Yi‐Ping Li, Jannick Prentoe, Anne Mette Hoegh, Lotte S. Mikkelsen, Jesper Eugen‐Olsen and Sanne B. Jensen.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact